Adoptive immunotherapy for hepatocellular carcinoma with MRI-monitored transcatheter delivery of ferumoxytol nanocomplex-labeled natural killer lymphocytes

Aims and objectives Methods and materials Results Conclusion Personal information References
Aims and objectives: Hepatocellular Carcinoma (HCC)is the 5th most common malignancy in the world. Surgical resection and transplantation are the sole potentially curative treatments for HCC, but only 10-15% of patients are candidates. Catheter-directed therapies, such...